EUVIMEDEUVIMED entdecken
Crossref

Cannabidiol-Loaded Nanostructured Lipid Carriers for Nose to Brain Delivery: An Effective Therapeutic Approach against Epilepsy

Liyan Wang, Li Yang, Kaili Liang, Bo Liu, Qing Luo, Wei Wang, Ding Zhang, Qing Wang iD

Molecular Pharmaceutics · 04.08.2025 · 22 (8) · 4804-4818

DOI: 10.1021/acs.molpharmaceut.5c00452 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Pharmaceutics, online erschienen am 22.07.2025. Verfasst von Liyan Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Fine Chemicals, Department of Pharmaceutical Engineering, School of Chemical Engineering, Dalian University of Technology, Da…. Hauptthemen laut MEDLINE: Cannabidiol, Lipids, Drug Carriers, Epilepsy. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 51 Literaturangaben. Gefördert von: Fundamental Research Funds for the Central Universities.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The presence of first-pass metabolism and the obstacle of the blood-brain barrier may reduce the effectiveness of oral antiepileptic medications. Nasal drug delivery has been considered a promising selective route to the brain for drugs with low aqueous solubility in the treatment of CNS disease. The purpose of our study was to improve the bioavailability as well as brain targetability of cannabidiol (CBD) by encapsulating it in nanostructured lipid carriers (NLCs) and delivering the formulation via the nasal route. CBD-NLCs were effectively prepared with the appropriate particle sizes and polydispersity index for the nasal route (77.71 nm± 0.79 and 0.23 ± 0.00, respectively). These particles demonstrated a high entrapment efficiency and drug loading of 99.24% ± 0.07 and 8.73% ± 0.56 w/w, respectively. According to the FTIR, XRD, and DSC data, CBD was either in the amorphous state or distributed molecularly in the lipid matrix. The absorption of CBD-NLCs in the nasal cavity was significantly superior to pure CBD (the rate constants were 9.02 ± 1.64 and 2.10 ± 0.25 μg/min, respectively). Compared to the intravenous administration of CBD, CBD-NLCs showed a drug targeting efficiency of 277.82% after nasal administration, indicating a more efficient brain targeting. In a rat model where seizure activity was induced by PTZ, intranasal administration of CBD-NLCs significantly prolonged seizure latency and decreased the Racine score. All of the results suggest CBD-NLCs administered intranasally might be a promising alternative to traditional epilepsy treatments.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CannabidiolLipidsDrug CarriersEpilepsyNanostructuresAnticonvulsantsBrainAnimalsAdministration, IntranasalRatsMaleParticle SizeBiological AvailabilityRats, Sprague-DawleyDrug Delivery SystemsNasal MucosaSolubilityPentylenetetrazoleBlood-Brain Barrier

Stichwörter der Autor:innen

antiepilepsybrain targetabilitycannabidiolnanostructured lipid carriersnose-to-brain deliveryphysicochemical characteristics

Substanzen

CannabidiolLipidsDrug CarriersAnticonvulsantsPentylenetetrazole

Autor:innen und Institutionen

  • State Key Laboratory of Fine Chemicals, Department of Pharmaceutical Engineering, School of Chemical Engineering, Dalian University of Technology, Dalian 116024, P.R. China.
  • Department of Pharmacy, The First Affiliated Hospital of Dalian Medical University, Dalian 116011, P.R. China.
  • Department of Nephrology, Dalian University Affiliated Xinhua Hospital, Dalian 116021, P.R. China.

ORCID-Profile: Qing Wang

Förderung

  • Fundamental Research Funds for the Central Universities

Zitieren

APA

Wang, L., Yang, L., Liang, K., Liu, B., Luo, Q., Wang, W., Zhang, D., & Wang, Q. (2025). Cannabidiol-Loaded Nanostructured Lipid Carriers for Nose to Brain Delivery: An Effective Therapeutic Approach against Epilepsy. Molecular Pharmaceutics, 22(8), 4804-4818. https://doi.org/10.1021/acs.molpharmaceut.5c00452

Vancouver

Wang L, Yang L, Liang K, Liu B, Luo Q, Wang W, et al. Cannabidiol-Loaded Nanostructured Lipid Carriers for Nose to Brain Delivery: An Effective Therapeutic Approach against Epilepsy. Molecular Pharmaceutics. 2025;22(8):4804-4818. doi:10.1021/acs.molpharmaceut.5c00452

BibTeX
@article{Wang2025,
  author = {Wang, Liyan and Yang, Li and Liang, Kaili and Liu, Bo and Luo, Qing and Wang, Wei and Zhang, Ding and Wang, Qing},
  title = {Cannabidiol-Loaded Nanostructured Lipid Carriers for Nose to Brain Delivery: An Effective Therapeutic Approach against Epilepsy},
  journal = {Molecular Pharmaceutics},
  year = {2025},
  volume = {22},
  number = {8},
  pages = {4804--4818},
  doi = {10.1021/acs.molpharmaceut.5c00452}
}
Kostenlos starten →